Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session

Gainers

• Dermata Therapeutics, Inc. (NASDAQ:DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
• Palisade Bio, Inc. (NASDAQ:PALI) shares jumped 80.1% to $5.80. Palisade Bio announced $2.5 million registered direct offering and concurrent private placement priced above market under Nasdaq rules.
• Silo Pharma, Inc. (NASDAQ:SILO) gained 63.7% to $5.60 after the company announced study results of SPU-21 for arthritis. The company said SPU-21 is effective in controlling arthritis progression.
• F-star Therapeutics, Inc. (NASDAQ:FSTX) shares gained 42.8% to $5.84. F-Star Therapeutics shares traded lower on Thursday after the Committee on Foreign Investment issued an interim order preventing the closing of the pending merger with Invox Pharma.
• Kala Pharmaceuticals, Inc. (NASDAQ:KALA) jumped 38% to $33.65. Kala Pharmaceuticals recently announced FDA acceptance of an IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.
• Charah Solutions, Inc. (NYSE:CHRA) gained 37.6% to $5.57. Charah Solutions reported receipt of notification letter from NYSE.
• Embark Technology, Inc. (NASDAQ:EMBK) gained 33% to $3.4686.
• NovaBay Pharmaceuticals, Inc. (NYSE:NBY) jumped 27.3% to $1.77.
• Allarity Therapeutics, Inc. (NASDAQ:ALLR) jumped 26.7% to $0.3679.
• Concord Medical Services Holdings Limited (NYSE:CCM) gained 23.8% to $1.6599.
• Mereo BioPharma Group plc (NASDAQ:MREO) surged 23.6% to $0.69.
• 9 Meters Biopharma, Inc. (NASDAQ:NMTR) gained 23% to $1.4450.
• Frequency Therapeutics, Inc. (NASDAQ:FREQ) jumped 22.5% to $3.97.
• Journey Medical Corporation (NASDAQ:DERM) surged 22% to $1.77. Journey Medical recently announced PK comparability data of DFD-29 and key updates on the progress of its pivotal, Phase 3 study of DFD-29 for papulopustular rosacea in collaboration with Dr. Reddy's Laboratories.
• Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) gained 21% to $1.3988.
• Protagenic Therapeutics, Inc. (NASDAQ:PTIX) gained 20% to $0.42.
• Tuesday Morning Corporation (NASDAQ:TUEM) rose 19.8% to $0.8195 after gaining around 16% on Thursday. Tuesday Morning recently announced it will voluntarily delist from the Nasdaq Capital Market.
• ECARX Holdings Inc. (NASDAQ:ECX) gained 17.8% to $8.00.
• BitNile Holdings, Inc. (NYSE:NILE) surged 17.5% to $0.1175. BitNile Holdings, Inc. reported Ault Alpha has purchased 50m shares of the company's common stock.
• Histogen Inc. (NASDAQ:HSTO) gained 17.5% to $0.94.
• Sesen Bio, Inc. (NASDAQ:SESN) shares rose 16.8% to $0.59 after the company and Carisma Therapeutics announced an increased special dividend of $70 million, or $0.34 per share, in connection with the pending merger.
• Scholar Rock Holding Corporation (NASDAQ:SRRK) gained 15.8% to $9.35.
• China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) rose 15.3% to $0.6012.
• Getaround, Inc. (NYSE:GETR) rose 13.5% to $0.5676 after dropping around 8% on Thursday. Piper Sandler initiated coverage on Getaround with an Overweight rating and announced a price target of $1.5.
• NaaS Technology Inc. (NASDAQ:NAAS) gained 12.9% to $3.3758. NaaS Technology appointed Alex Wu as its Chief Financial Officer, effective January 15, 2023.
• EZGO Technologies Ltd. (NASDAQ:EZGO) surged 12% to $0.58.
• Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) gained 11.8% to $0.2025.
• The Lion Electric Company (NYSE:LEV) gained 11.5% to $2.31.
• Lightning eMotors, Inc. (NYSE:ZEV) shares rose 11.1% to $0.3629. Lightning eMotors recently received continued listing standards notice from NYSE.
• Kineta, Inc. (NASDAQ:KA) gained 9.8% to $6.71.
• Shaw Communications Inc. (NYSE:SJR) rose 9.3% to $28.91 following the decision summary by the Competition Tribunal allowing the proposed acquisition of Freedom Mobile by Videotron, and the subsequent combination of Rogers and Shaw to proceed.
• Blink Charging Co. (NASDAQ:BLNK) gained 9.1% to $11.12.
• Rogers Communications Inc. (NYSE:RCI) surged 5.6% to $47.61.

Losers

• Futu Holdings Limited (NASDAQ:FUTU) fell 24.8% to $44.27. Tencent Holding backed Chinese online broker Futu Holdings unexpectedly deferred its Hong Kong listing less than a day before its anticipated debut on December 30.
• UP Fintech Holding Limited (NASDAQ:TIGR) shares dipped 24% to $3.63 after the China Securities Regulatory Commission reported the companies have conducted illegal securities business.
• Scilex Holding Company (NASDAQ:SCLX) dropped 22% to $3.1189.
• Hoth Therapeutics, Inc. (NASDAQ:HOTH) fell 19% to $8.69 after the company announced a $10 million private placement priced at-the-market under Nasdaq rules.
• Shineco, Inc. (NASDAQ:SISI) dropped 17.4% to $1.85.
• ReShape Lifesciences Inc. (NASDAQ:RSLS) fell 17.2% to $6.36. Reshape Lifesciences recently announced a 1-for-50 reverse stock split.
• Secoo Holding Limited (NASDAQ:SECO) dropped 11.7% to $1.88.
• TransCode Therapeutics, Inc. (NASDAQ:RNAZ) dropped 11.3% to $0.5058. TransCode Therapeutics recently announced it received written authorization from the FDA that it may proceed with its First-in-Human Phase 0 clinical trial.
• Drive Shack Inc. (NYSE:DS) dropped 10.2% to $0.1870. Drive Shack recently announced the intention to voluntarily delist and deregister its securities.
• Accelerate Diagnostics, Inc. (NASDAQ:AXDX) dipped 9.9% to $0.5665.
• Unicycive Therapeutics, Inc. (NASDAQ:UNCY) dropped 9.8% to $0.4990. Unicycive recently announced termination of 'at-the-market' offering of shares of common stock.
• Rubius Therapeutics, Inc. (NASDAQ:RUBY) shares fell 8.9% to $0.1753 after declining around 20% on Thursday. Rubius Therapeutics, last month, initiated a process to explore a range of strategic alternatives and plans to engage an investment bank to act as a strategic advisor for this process.
• Quotient Limited (NASDAQ:QTNT) fell 6.5% to $0.3460 after jumping 54% on Thursday.

Also Check This Out $2.5 Million Bet On CrowdStrike Holdings? Check Out These 4 Stocks Insiders Are Buying